Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Return on Equity (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Return on Equity for 14 consecutive years, with 0.97% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 29.0% to 0.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.97% through Dec 2025, down 29.0% year-over-year, with the annual reading at 0.71% for FY2025, 12.0% down from the prior year.
  • Return on Equity hit 0.97% in Q4 2025 for Cardiff Oncology, down from 0.94% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.16% in Q1 2021 to a low of 0.97% in Q4 2025.
  • Historically, Return on Equity has averaged 0.51% across 5 years, with a median of 0.48% in 2023.
  • Biggest five-year swings in Return on Equity: soared 234bps in 2021 and later tumbled -33bps in 2024.
  • Year by year, Return on Equity stood at 0.21% in 2021, then plummeted by -73bps to 0.36% in 2022, then tumbled by -58bps to 0.57% in 2023, then dropped by -20bps to 0.69% in 2024, then tumbled by -42bps to 0.97% in 2025.
  • Business Quant data shows Return on Equity for CRDF at 0.97% in Q4 2025, 0.94% in Q3 2025, and 0.79% in Q2 2025.